Dr. Michael Engelbert - MD, PhD

Dr. Michael Engelbert - MD, PhD

  • 460 Park Avenue
  • 5th Floor
  • New York, NY  10022
  •  (212) 861-9797/ Phone

Practice Name:

Vitreous Retina Macula Consultants of New York

See below for the Doctor's other office locations.


  • Ophthalmologist


  • Ophthalmology

Professional Statement:

Michael Engelbert M.D. Ph.D. is a vitreoretinal surgeon and medical retina specialist at Vitreous Retina Macula Consultants of New York in Manhattan.

Dr. Engelbert received his medical degree Magna Cum Laude after which he dedicated himself several years to basic research in the ... more...


  • Ludwig Maximilian University (Medical School)
  • NewYork-Presbyterian Hospital / Columbia University Medical Center, Residency in Ophthalmology
  • Griffin Hospital, Internship in Internal Medicine
  • Columbia University, Manhattan Eye, Ear and Throat Hospital, Fellowship in Medical and Surgical Vitreoretinal Disease

Languages Spoken:

  • English
  • French
  • Spanish
  • German
  • Italian

Board Certifications:

  • American Board of Ophthalmology

Professional Memberships:

  • American Society of Retina Specialists
  • European Society of Vitreoretinal Specialists
  • Association for Research in Vision and Ophthalmology
  • American Academy of Ophthalmology
  • American Society for Cataract and Refractive Surgery
  • New York State Ophthalmological Society

Awards and Publications:

  • Circle of Excellence, Arnold P. Gold Foundation's Humanism and Excellence in Teaching Award
  • Molecular Pathogenesis of Infectious and Inflammatory Eye Research (MPIIER) Travel Award 2001
  • Engelbert, M. and M.S.Gilmore. 2005. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol.Vis.Sci. 46:2479-2486.
  • Engelbert, M., E.Mylonakis, F.M.Ausubel, S.B.Calderwood, and M.S.Gilmore. 2004. Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect.Immun. 72:3628-3633.
  • Engelbert, M., H. Miño de Kaspar, M.Thiel, T.Grasbon, C.N.Ta, M.Schulze-Schwering, V.Klauss, and A.Kampik. 2004. Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis. Graefes Arch.Clin.Exp.Ophthalmol. 242:313-320.